Mvabea
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mvabea, covering 2025-05-14 to 2025-05-14. Get the full timeline:
Most recent: EMA Authorised: Mvabea (recombinant Modified Vaccinia Ankara Bavarian Nordic Virus encoding the: Ebola virus Zaire (ZEBOV) Mayinga strain glycoprotein (GP); Ebola virus Sudan Gulu strain GP; Ebola virus Taï Forest strain nucleoprotein and the Marburg virus Musoke strain GP) — Janssen-Cilag International N.V.